BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Biocryst Pharmaceuticals 

2190 Parkway Lake Drive

Birmingham  Alabama  35244  U.S.A.
Phone: 205-444-4600 Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology


Collaborations

Affinimark Technologies Inc. 





 Company News
Biocryst Pharmaceuticals (BCRX) Initiates Opus-2: A Clinical Trial Of BCX4161 In Patients With Hereditary Angioedema 12/18/2014 7:41:07 AM
Biocryst Pharmaceuticals (BCRX) Announces Initiation Of A Phase 1 Clinical Trial Of BCX4430 For The Treatment Of Hemorrhagic Fever Viruses 12/15/2014 7:21:55 AM
Biocryst Pharmaceuticals (BCRX) To Present At Two Upcoming Investor Conferences 11/20/2014 2:08:44 PM
Biocryst Pharmaceuticals (BCRX) Reports Third Quarter 2014 Financial Results 11/6/2014 10:52:05 AM
Ebola Clinical Trials: Big Name Players In The Ebola Race 10/20/2014 3:28:01 AM
Biocryst Pharmaceuticals (BCRX) To Launch NHP Ebola Drug Safety, Efficacy Studies "Within Weeks" 10/10/2014 3:22:11 PM
Biocryst Pharmaceuticals (BCRX) Release: RAPIVAB™ Trial Results For The Treatment Of Influenza To Be Presented At IDWeek 2014 10/8/2014 7:13:57 AM
Biocryst Pharmaceuticals (BCRX) Announces Late Breaker Presentation Of Opus-1 Phase 2 Trial Results At The 23rd EADV Congress 10/7/2014 7:34:13 AM
Biocryst Pharmaceuticals (BCRX) Receives Additional National Institute of Allergy And Infectious Diseases (NIAID) Funding For Manufacture And Development Of BCX4430 To Treat Hemorrhagic Virus Diseases 9/18/2014 11:20:04 AM
Biocryst Pharmaceuticals (BCRX) Announces RAPIVAB™ Trial Results For The Treatment Of Influenza At The ICAAC 2014 Meeting 9/8/2014 7:38:22 AM
12345678910...